EUVIMEDOpdag EUVIMED
Crossref

The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors

Tarik Sengoz iD, Merve Yucel Kahraman iD, Yusuf Ozlulerden, Sinan Celen

Nuclear Medicine Review · 2026

DOI: 10.5603/nmr.113240 ↗

At a glance

Journal article in Nuclear Medicine Review, 2026. Written by Tarik Sengoz and 3 co-authors. Institution: Pamukkale University, Medical Faculty, Department of Nuclear Medicine, Denizli, Turkiye. tsengoz@pau.edu.tr. Major MEDLINE topics: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Kidney Neoplasms, Glutamate Carboxypeptidase II.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: In this study, we compared the diagnostic performances of [¹⁸F]FDG PET/CT and [⁶⁸Ga]Ga-PSMA PET/CT in the evaluation of primary kidney tumors. MATERIAL AND METHODS: Preoperative dual-tracer PET/CT imaging was performed on patients with kidney tumors. Demographic data and pathological parameters were obtained. SUVmax and the tumor-to-background ratio (TBR) of primary renal tumor were calculated on both PET/CT images. Patients were divided into two groups based on the concordance of [¹⁸F]FDG PET/CT and [⁶⁸Ga]Ga-PSMA PET/CT: concordant negative (no PSMA or FDG uptake) and concordant positive (PSMA-FDG uptake). The concordant positive group was divided into three groups: high PSMA (PSMA > FDG), high FDG (FDG > PSMA), and PSMA = FDG. RESULTS: Of the 12 patients included in the study, 11 (91.7%) were male and 1 (8.3%) was female. The mean age was 59.5 ± 15.21 (31-82) years. Pathological evaluation revealed oncocytoma in 2 patients (16.7%) and renal cell carcinoma in 10 patients (83.3%). In the correlation analysis, a very weak negative relationship was found between SUVmaxpFDG and SUVmaxpPSMA (p = 0.463; r = -0.246), while a strong positive relationship was found between TBRFDG and TBRPSMA (p = 0.007; r = 0.755). Metastasis was detected in 3 patients (25%) (tumor embolism in one patient and lung metastasis in two patients). Two patients (16.7%) were in the concordant negative group and 10 patients (83.3%) were in the concordant positive group. CONCLUSIONS: For PET imaging in RCC, [⁶⁸Ga]Ga-PSMA PET/CT is compatible with [¹⁸F]FDG PET/CT; these two examinations can be used together. [⁶⁸Ga]Ga-PSMA expression in lesions is higher than [¹⁸F]FDG uptake. However, due to the high renal uptake in both examinations, the use of TBR will be more accurate than SUVmax.

Subjects

MeSH terms (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Kidney NeoplasmsGlutamate Carboxypeptidase IIHumansMaleFemaleMiddle AgedAgedAged, 80 and overAdultRadioactive Tracers

Author keywords

fluorodeoxyglucosepositron emission tomographyprostate-specific membrane antigenrenal cell carcinoma

Substances

Fluorodeoxyglucose F18Glutamate Carboxypeptidase IIRadioactive Tracers

Authors and institutions

  • Pamukkale University, Medical Faculty, Department of Nuclear Medicine, Denizli, Turkiye. tsengoz@pau.edu.tr.
  • Denizli State Hospital, Department of Nuclear Medicine, Denizli, Turkiye.
  • Pamukkale University, Medical Faculty, Department of Urology, Denizli, Turkiye.

ORCID profiles: Tarik Sengoz, Merve Yucel Kahraman

Cite

APA

Sengoz, T., Kahraman, M. Y., Ozlulerden, Y., & Celen, S. (2026). The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors. Nuclear Medicine Review. https://doi.org/10.5603/nmr.113240

Vancouver

Sengoz T, Kahraman MY, Ozlulerden Y, Celen S. The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors. Nuclear Medicine Review. 2026. doi:10.5603/nmr.113240

BibTeX
@article{Sengoz2026,
  author = {Sengoz, Tarik and Kahraman, Merve Yucel and Ozlulerden, Yusuf and Celen, Sinan},
  title = {The role of dual tracer PSMA and [18F]FDG PET/CT in primary renal tumors},
  journal = {Nuclear Medicine Review},
  year = {2026},
  doi = {10.5603/nmr.113240}
}
Start for free →